Annual Accounts Receivable
$43.61 M
-$9.22 M-17.45%
May 31, 2024
Summary
- As of February 8, 2025, ANGO annual accounts receivable is $43.61 million, with the most recent change of -$9.22 million (-17.45%) on May 31, 2024.
- During the last 3 years, ANGO annual accounts receivable has risen by +$8.21 million (+23.17%).
- ANGO annual accounts receivable is now -29.62% below its all-time high of $61.97 million, reached on May 31, 2014.
Performance
ANGO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$43.16 M
+$3.60 M+9.09%
November 30, 2024
Summary
- As of February 8, 2025, ANGO quarterly accounts receivable is $43.16 million, with the most recent change of +$3.60 million (+9.09%) on November 30, 2024.
- Over the past year, ANGO quarterly accounts receivable has dropped by -$452.00 thousand (-1.04%).
- ANGO quarterly accounts receivable is now -30.35% below its all-time high of $61.97 million, reached on May 31, 2014.
Performance
ANGO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ANGO Accounts Receivable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -17.4% | -1.0% |
3 y3 years | +23.2% | +13.0% |
5 y5 years | +0.1% | +27.0% |
ANGO Accounts Receivable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -17.4% | +23.2% | -19.5% | +13.0% |
5 y | 5-year | -17.4% | +39.5% | -19.5% | +38.0% |
alltime | all time | -29.6% | +877.6% | -30.4% | +560.7% |
AngioDynamics Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Nov 2024 | - | $43.16 M(+9.1%) |
Aug 2024 | - | $39.56 M(-9.3%) |
May 2024 | $43.61 M(-17.4%) | $43.61 M(-11.9%) |
Feb 2024 | - | $49.48 M(-4.1%) |
Nov 2023 | - | $51.60 M(+3.7%) |
Aug 2023 | - | $49.76 M(-5.8%) |
May 2023 | $52.83 M(+1.0%) | $52.83 M(+3.8%) |
Feb 2023 | - | $50.89 M(-3.7%) |
Nov 2022 | - | $52.85 M(-1.4%) |
Aug 2022 | - | $53.59 M(+2.5%) |
May 2022 | - | $52.30 M(+25.1%) |
May 2022 | $52.30 M(+47.7%) | - |
Feb 2022 | - | $41.81 M(+9.4%) |
Nov 2021 | - | $38.20 M(+7.9%) |
Aug 2021 | - | $35.42 M(+0.0%) |
May 2021 | $35.41 M(+13.2%) | $35.41 M(+6.7%) |
Feb 2021 | - | $33.17 M(-1.3%) |
Nov 2020 | - | $33.60 M(+0.0%) |
Aug 2020 | - | $33.59 M(+7.4%) |
May 2020 | $31.26 M(-28.3%) | $31.26 M(-12.2%) |
Feb 2020 | - | $35.62 M(+4.8%) |
Nov 2019 | - | $33.99 M(+4.5%) |
Aug 2019 | - | $32.54 M(-25.3%) |
May 2019 | $43.58 M(+10.6%) | $43.58 M(-1.4%) |
Feb 2019 | - | $44.21 M(+1.9%) |
Nov 2018 | - | $43.37 M(+8.0%) |
Aug 2018 | - | $40.16 M(+1.9%) |
May 2018 | $39.40 M(-11.5%) | $39.40 M(-5.8%) |
Feb 2018 | - | $41.83 M(-0.6%) |
Nov 2017 | - | $42.07 M(+1.9%) |
Aug 2017 | - | $41.28 M(-7.3%) |
May 2017 | $44.52 M(-15.8%) | $44.52 M(-3.8%) |
Feb 2017 | - | $46.30 M(-7.7%) |
Nov 2016 | - | $50.17 M(+0.1%) |
Aug 2016 | - | $50.12 M(-5.2%) |
May 2016 | $52.87 M(-9.5%) | $52.87 M(-2.9%) |
Feb 2016 | - | $54.45 M(+2.5%) |
Nov 2015 | - | $53.12 M(+1.3%) |
Aug 2015 | - | $52.42 M(-10.3%) |
May 2015 | $58.43 M(-5.7%) | $58.43 M(+1.1%) |
Feb 2015 | - | $57.77 M(-1.3%) |
Nov 2014 | - | $58.56 M(+4.5%) |
Aug 2014 | - | $56.03 M(-9.6%) |
Date | Annual | Quarterly |
---|---|---|
May 2014 | $61.97 M(+30.0%) | $61.97 M(+7.3%) |
Feb 2014 | - | $57.73 M(+19.3%) |
Nov 2013 | - | $48.41 M(+4.0%) |
Aug 2013 | - | $46.56 M(-2.3%) |
May 2013 | $47.68 M(-1.9%) | $47.68 M(+5.7%) |
Feb 2013 | - | $45.11 M(-4.2%) |
Nov 2012 | - | $47.09 M(+3.6%) |
Aug 2012 | - | $45.43 M(-6.5%) |
May 2012 | $48.59 M(+79.0%) | $48.59 M(+81.8%) |
Feb 2012 | - | $26.72 M(-15.0%) |
Nov 2011 | - | $31.45 M(+19.3%) |
Aug 2011 | - | $26.36 M(-2.9%) |
May 2011 | $27.14 M(-9.0%) | $27.14 M(-4.6%) |
Feb 2011 | - | $28.46 M(+10.5%) |
Nov 2010 | - | $25.76 M(+9.0%) |
Aug 2010 | - | $23.64 M(-20.8%) |
May 2010 | $29.84 M(+9.8%) | $29.84 M(+12.4%) |
Feb 2010 | - | $26.54 M(+4.5%) |
Nov 2009 | - | $25.40 M(+8.6%) |
Aug 2009 | - | $23.38 M(-14.0%) |
May 2009 | $27.18 M(+2.0%) | $27.18 M(+2.6%) |
Feb 2009 | - | $26.50 M(+3.0%) |
Nov 2008 | - | $25.73 M(+5.6%) |
Aug 2008 | - | $24.38 M(-8.5%) |
May 2008 | $26.64 M(+28.1%) | $26.64 M(+17.0%) |
Feb 2008 | - | $22.76 M(+2.5%) |
Nov 2007 | - | $22.22 M(+12.9%) |
Aug 2007 | - | $19.69 M(-5.3%) |
May 2007 | $20.80 M(+54.2%) | $20.80 M(+9.9%) |
Feb 2007 | - | $18.93 M(+33.2%) |
Nov 2006 | - | $14.21 M(+17.1%) |
Aug 2006 | - | $12.13 M(-10.0%) |
May 2006 | $13.49 M(+35.8%) | $13.49 M(+10.7%) |
Feb 2006 | - | $12.18 M(+12.7%) |
Nov 2005 | - | $10.81 M(+14.0%) |
Aug 2005 | - | $9.48 M(-4.5%) |
May 2005 | $9.93 M(-64.4%) | $9.93 M(+18.9%) |
Feb 2005 | - | $8.35 M(+5.2%) |
Nov 2004 | - | $7.94 M(+10.6%) |
Aug 2004 | - | $7.18 M(-74.3%) |
May 2004 | $27.89 M(+327.0%) | $27.89 M(+280.4%) |
Feb 2004 | - | $7.33 M(+12.2%) |
May 2003 | $6.53 M(+46.4%) | $6.53 M |
May 2002 | $4.46 M | - |
FAQ
- What is AngioDynamics annual accounts receivable?
- What is the all time high annual accounts receivable for AngioDynamics?
- What is AngioDynamics annual accounts receivable year-on-year change?
- What is AngioDynamics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for AngioDynamics?
- What is AngioDynamics quarterly accounts receivable year-on-year change?
What is AngioDynamics annual accounts receivable?
The current annual accounts receivable of ANGO is $43.61 M
What is the all time high annual accounts receivable for AngioDynamics?
AngioDynamics all-time high annual accounts receivable is $61.97 M
What is AngioDynamics annual accounts receivable year-on-year change?
Over the past year, ANGO annual accounts receivable has changed by -$9.22 M (-17.45%)
What is AngioDynamics quarterly accounts receivable?
The current quarterly accounts receivable of ANGO is $43.16 M
What is the all time high quarterly accounts receivable for AngioDynamics?
AngioDynamics all-time high quarterly accounts receivable is $61.97 M
What is AngioDynamics quarterly accounts receivable year-on-year change?
Over the past year, ANGO quarterly accounts receivable has changed by -$452.00 K (-1.04%)